Home › Non-Small Cell Lung Cancer › Florida › Boca Raton
Non-Small Cell Lung Cancer clinical trials in Boca Raton, FL
4 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Boca Raton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Baptist Lynn Cancer Institute, Boca Raton
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RecruitingPhase 3
- Boca Raton Regional Hospital, Boca Raton
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RecruitingPhase 1/2
- MDR Core Network, Boynton Beach · 12 mi away
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RecruitingPhase 3
- Lynn Cancer Institute Center, Boca Raton
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY120 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH56 studies
- Washington, DC55 studies
Other studies in Boca Raton
- Myasthenia Gravis10 studies
- Alzheimer's Disease8 studies
- Parkinson's Disease8 studies
- Overweight7 studies
- Obesity7 studies
- Type 2 Diabetes6 studies
- High Blood Pressure5 studies
- Cardiovascular Disease5 studies
- Heart Failure5 studies
- Breast Cancer4 studies
- Chronic Kidney Disease4 studies
- COPD4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.